221 related articles for article (PubMed ID: 30684967)
1. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma.
Meng W; Cui W; Zhao L; Chi W; Cao H; Wang B
J Biomed Sci; 2019 Jan; 26(1):13. PubMed ID: 30684967
[TBL] [Abstract][Full Text] [Related]
2. Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma.
Dong Z; Li S; Wu X; Niu Y; Liang X; Yang L; Guo Y; Shen S; Liang J; Guo W
Cell Death Dis; 2019 Dec; 10(12):930. PubMed ID: 31804468
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation-mediated downregulation of the LINC01554 gene accelerates the malignant progression and regulates the chemosensitivity of laryngeal squamous cell carcinoma.
Wang J; Meng W; Yang J; Cao H; Liu T; Yang C; Yu M; Wang B
J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 35988928
[TBL] [Abstract][Full Text] [Related]
6. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA hypermethylation-silenced LINC00886 gene accelerates malignant progression of laryngeal carcinoma.
Lan L; Cao H; Chi W; Meng W; Zhao L; Cui W; Wang B
Pathol Res Pract; 2020 Apr; 216(4):152877. PubMed ID: 32111441
[TBL] [Abstract][Full Text] [Related]
8. IncRNA ZNF667-AS1 Suppresses Epithelial Mesenchymal Transformation by Targeting TGF-β1 in Oral Squamous Cell Carcinoma.
Zhao J; Cui Z; Dong Z; Niu Y; Yang K; Han H
Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258957
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
[TBL] [Abstract][Full Text] [Related]
10. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
He L; Ji W; Yang J; Zhao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
[TBL] [Abstract][Full Text] [Related]
11. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
[TBL] [Abstract][Full Text] [Related]
13. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
[TBL] [Abstract][Full Text] [Related]
14. Expression of CBY and methylation of CBY at promoter region in human laryngeal squamous cell carcinoma.
Ren G; Zhao DA; Xu J; Li BA
Tumori; 2015; 101(2):215-22. PubMed ID: 25838250
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNA ST7-AS1 promotes laryngeal squamous cell carcinoma by stabilizing CARM1.
Qin H; Xu J; Gong L; Jiang B; Zhao W
Biochem Biophys Res Commun; 2019 Apr; 512(1):34-40. PubMed ID: 30853182
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
17. The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma.
Wang J; Chen H; Fu S; Xu ZM; Sun KL; Fu WN
Oral Oncol; 2011 Jul; 47(7):601-8. PubMed ID: 21636313
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer.
Yang CM; Wang TH; Chen HC; Li SC; Lee MC; Liou HH; Liu PF; Tseng YK; Shiue YL; Ger LP; Tsai KW
Clin Epigenetics; 2016; 8():129. PubMed ID: 27933111
[TBL] [Abstract][Full Text] [Related]
19. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B
Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
